DeepSynapsCLINICAL INTELLIGENCE OS
Research overview

Neuromodulation research in numbers: 28 treatments and conditions compared

How much research exists for each neuromodulation treatment and condition? The DeepSynaps evidence maps count the papers tagged to 28 treatment and condition pairs in a corpus of 152,371 indexed papers (snapshot 2026-09-25). This article puts all 28 side by side.

DeepSynaps · · data snapshot 2026-09-25

All 28 evidence maps at a glance

Sorted by the number of papers. Each row links to its evidence map, which lists the most-cited trials and reviews with links to their sources.

Where the randomised trials are

The five maps with the most randomised controlled trials:

  1. rTMS for major depressive disorder: 713 RCTs among 3,320 papers
  2. tDCS for depression: 344 RCTs among 1,232 papers
  3. DBS for Parkinson’s disease: 242 RCTs among 9,164 papers
  4. VNS for treatment-resistant depression: 91 RCTs among 1,043 papers
  5. Deep TMS for OCD: 82 RCTs among 491 papers

Fastest-growing research areas

Papers published in 2021–2025 compared with 2016–2020, for maps with at least 50 papers in the earlier period:

  1. VNS for post-stroke arm rehabilitation: 52 papers in 2016–2020, 216 in 2021–2025 (4.2×)
  2. HNS for obstructive sleep apnea: 89 papers in 2016–2020, 266 in 2021–2025 (3.0×)
  3. Deep TMS for OCD: 98 papers in 2016–2020, 261 in 2021–2025 (2.7×)
  4. Neurofeedback for anxiety and PTSD: 56 papers in 2016–2020, 144 in 2021–2025 (2.6×)
  5. VNS for treatment-resistant depression: 176 papers in 2016–2020, 437 in 2021–2025 (2.5×)

How to read these numbers

Each map counts papers tagged to that treatment and condition in the curated DeepSynaps v6 corpus; papers Jev confidently judged off-topic are excluded. Counts describe how much has been published, not how well the treatment works.

Study designs are AI-classified by Jev: advisory, not clinician-reviewed. Some papers on each map have no confident study-design label yet, so the trial and review columns are lower bounds.

Totals include papers from 2026, which was still in progress at the snapshot (2026-09-25). The growth comparison uses complete years only.

Decision support only. This article summarises published literature; it is not medical advice or a recommendation for any patient. Data snapshot 2026-09-25.